Did the sales cycle slow down, or did the deal mix change?

The average sales cycle has risen from 48 to 62 days. The CRO asks why sellers are taking longer and whether a new close-plan requirement would help. The team starts gathering anecdotes about procurement and follow-up. Before the meeting ends, an operating change is nearly approved on the strength of one blended number.

First compare like with like. A longer overall cycle can result from more complex deals making up a larger share of wins, even when execution within every segment improves. It can also reflect a different measurement start, a backlog closing or an immature cohort. RevOps should separate mix, timing and within-group changes before recommending a process intervention. The question is which part of the buying journey changed, for which population, and with what evidence.

State the clock and the population

“Sales cycle” is incomplete without a start event and an end event. Opportunity creation to closed-won may be useful for one purpose. First qualified buyer conversation to signature may answer another. Neither should silently replace the other in a trend. A change in when opportunities are created can shorten the recorded cycle without changing the customer's buying experience.

Also state which deals are included. Closed-won deals describe the journeys of wins. Closed-lost deals and still-open opportunities carry different information. A closed-won average cannot establish that all current opportunities are progressing faster, because the unfinished journeys are absent.

HubSpot's sales-velocity guidance, updated May 7, 2025 and checked October 16, 2026, recommends separating market segments and keeping definitions consistent. The analysis here extends that principle into a practical diagnostic sequence. It does not use HubSpot's customer results as a benchmark or claim that any particular cycle length is appropriate for your business.

A fictional average moves in the wrong direction

Suppose the previous quarter closed 80 small-business deals averaging 30 days and 20 enterprise deals averaging 120 days. The combined average is 48 days: 4,800 total deal-days divided by 100 wins. In the current quarter, 60 small-business wins average 28 days and 40 enterprise wins average 112 days. The combined average is 61.6 days.

Both segments became faster in this fictional example. The overall figure rose because enterprise doubled its share of the wins. A blanket instruction to accelerate every seller would respond to the composition of the business as though it were a deterioration in execution.

Hold the old mix constant as a diagnostic: 80% at 28 days plus 20% at 112 days gives 44.8 days. Compared with the prior 48-day figure, the within-segment change is a 3.2-day improvement at the old weights. The remaining difference between 44.8 and 61.6 reflects the changed mix under this simple two-group calculation. This is a transparent comparison, not a causal model or a forecast.

The CRO's next question should be commercial: was the shift toward enterprise intentional, and does the plan allow for that motion's longer timeline and resource needs? The team may still need process improvements. The blended average simply has not identified them.

Use cohorts to avoid judging unfinished journeys

A close-date view groups deals by when they finished. An entry cohort groups them by when they began the defined journey. These views answer different questions. A close-date report can be useful for describing completed business. An entry cohort helps examine what happened to opportunities that started under similar conditions.

Recent entry cohorts have had less time to finish. If you compare only their closed wins with all wins from an older cohort, the recent group may look artificially fast because its slow deals are still open. Keep the observation window explicit and include open counts and ages. Do not replace unknown final duration with zero or treat open opportunities as losses merely to complete a table.

For a practical management review, compare cohorts after the same elapsed observation period and show the unresolved share. If the sales motion regularly extends beyond that period, say so. More advanced time-to-event analysis may be useful with appropriate expertise, but the first improvement is usually simpler: stop presenting a partially observed group as if its journey were complete.

Consider a second, fictional view: twenty comparable opportunities entered each of two monthly cohorts. At day sixty, the earlier cohort had eight wins, four losses and eight still open; the later one has six wins, three losses and eleven still open. The later cohort’s six wins averaged fewer days, but that does not show the whole cohort became faster. More of its journeys remain unresolved. Bring the open ages and specific stalled milestones to the review before interpreting the faster completed subset as an improvement.

Find the change inside a comparable group

Keep the historical segment assignment needed for the comparison. Reclassifying all old deals under a new segmentation policy may be useful, but label that recalculated view. Otherwise a territory redesign or changed company-size threshold can look like a change in buyer behavior when the underlying journeys did not change.

Once the mix and maturity are visible, inspect the segment where duration actually changed. Compare deal size, product, source, new-versus-existing customer and relevant buying complexity without slicing the data into tiny cells that cannot support a conclusion. Use a small number of distinctions that the sales motion gives you reason to expect will matter.

Then examine the distribution and the underlying cases. A few very old wins can move the mean while the typical deal is unchanged. A median can add context, but it does not explain why the slowest deals matter. Keep counts and both ordinary and unusual cases visible. A material enterprise opportunity may deserve attention even if it has little effect on the median.

Suppose the current enterprise cohort is slower specifically between agreed evaluation and technical acceptance. Read the relevant histories. Was access delayed? Did the buyer change scope? Was a specialist unavailable? Was the milestone recorded late? The same elapsed time can reflect very different operating conditions. A diagnosis requires the buyer evidence, not just the stage label.

Choose an intervention that matches the evidence

If the main change is an intentional move upmarket, the response may be a revised capacity plan and expectations for pipeline timing. If comparable deals wait for technical resources, examine specialist allocation. If buyers repeatedly enter evaluations without agreed criteria, improve evaluation design. If a single large agreement waited for a known legal issue, avoid imposing a new process on every deal.

Keep one primary change in a bounded test when possible. Define the cohort, the event being improved and the observation period. Watch for side effects: earlier disqualification can shorten the surviving cycle while reducing total wins, and premature opportunity creation can lengthen the recorded cycle while improving visibility. Neither should be judged through duration alone.

The point is not to make the number smaller at any cost. It is to help buyers make well-supported decisions and help the company allocate attention responsibly. A longer evaluation can be appropriate when the purchase is more consequential. RevOps should make that trade-off visible rather than rewarding a metric change that merely moves work outside the measured clock.

Prepare the review so managers can discuss the buyer

RevTech's managed agents can carry agreed recurring analysis, connected context preparation and coordination. A useful scope might prepare the dated changes and source evidence a manager needs for a defined set of opportunities. Confirm the actual sources and current workflow before relying on that preparation; a managed service does not remove the need for an approved metric definition or a human interpretation of the buyer's situation.

The customer owns the grouping rules, business priorities, permissions and designated review. The prepared output should distinguish observed events, missing history and proposed explanations. That lets managers spend their time discussing what the buyer needs instead of reconstructing the record.

Before introducing another close-plan field, ask for a one-page explanation of the changed number: the clock, the population, the mix, the cohort maturity and the cases that support a specific intervention. If those elements do not identify a problem, keep investigating. A careful explanation can prevent a broad process change that asks every seller to solve a problem only the aggregate created.